FABP1 and metabolic syndrome: As a result, both FABP1 and FABP2 are associated with diseases accompanied by dysregulated lipid levels, such as metabolic syndrome, non-alcoholic fatty liver disease, and type 2 diabetes (Liu et al., 2015; Zare-Feyzabadi et al., 2022).